← Back
$GILD All transactions

GILEAD SCIENCES, INC.

▼ SELL 10b5-1 Plan

$ Value

$398K

Shares

3,584

Price

$111

Filed

Jun 2

Insider

Name

O'Day Daniel Patrick

Title

Chairman & CEO

CIK

0001638643

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

620,268

Footnotes

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. | Sale prices reported for the transactions reported here range from $109.68 to $110.67. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. | Sale prices reported for the transactions reported here range from $110.68 to $111.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Filing Info

Accession No.

0001127602-25-016281

Form Type

4

Issuer CIK

0000882095

O'Day Daniel Patrick's History

Date Ticker Type Value
2026-03-27 GILD $1.4M
2026-03-10 GILD M
2026-03-10 GILD F $1.5M
2026-03-10 GILD M
2026-03-10 GILD A
2026-03-10 GILD A $0
2026-02-27 GILD A $0
2026-02-27 GILD $501K
2026-02-27 GILD $932K
2026-02-27 GILD $15K

Other Insiders at GILD (90d)

Insider Bought Sold Last
Dickinson Andrew D
Chief Financial Officer
$896K 2026-03-16
Dickinson Andrew D / Mercier Johanna
Chief Financial Officer
$423K 2026-04-15
O'Day Daniel Patrick
Chairman & CEO
$21.6M 2026-03-27
Berger Dietmar
Chief Medical Officer
2026-03-10
Mercier Johanna
Chief Comm & Corp Aff Officer
$4.8M 2026-03-16
Burkhart Erin
SVP, Controllership
2026-03-10
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
2026-03-10